Breast implant lymphoma patient registry
Part of Cancer, Skin clinical trials.
This study is a registry that collects information from adults diagnosed with lymphoma that may be linked to breast implants. It helps researchers understand the condition better and may guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have a diagnosis of anaplastic large cell lymphoma.
- Your doctors believe it is linked to a breast implant.
- You are able to share your medical and treatment information with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well BV-CHP works in real-world patients with a type of lymphoma called anaplastic large cell lymphoma (ALCL). It also collects leftover tissue samples to learn more about the disease.
This trial helps create a research “tissue registry” by collecting breast cancer tissue samples and medical information. It may help doctors better understand inflammatory or invasive breast cancer and improve future studies.
This study collects blood samples from people with inflammatory breast cancer (IBC) to learn more about the disease. It uses a special blood test called Signatera to look for cancer DNA, and the information is stored in a registry for research.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
This study tests if performing immediate lymphatic reconstruction during lymph node removal can prevent lymphedema (arm swelling) in women with inflammatory breast cancer. If you qualify, the procedure may help lower your risk of long-term swelling.
This study collects health information from adults with invasive lobular breast cancer that has spread (metastatic) to help researchers understand factors linked to survival. Joining may help build better knowledge for future treatments and care planning.
Hear when a new Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.